Carlyle Group in $3.8bn deal for NBTY
PRIVATE equity company The Carlyle Group has agreed to buy vitamin maker NBTY for $3.8bn (£2.4bn).
NBTY said Carlyle will acquire all of NBTY’s outstanding shares for $55 per share, a 47 per cent premium above the stock’s closing price of $37.47 on Wednesday.
The deal is expected to close by the end of the year.
NBTY makes nutritional supplements and vitamins under the brands Nature’s Bounty, Vitamin World and others.